Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

GSK-NIH Ebola Vaccine to Enter Safety Testing

August 28, 2014 2:00 pm | by Seth Borenstein, AP Science Writer | News | Comments

Federal researchers next week will start testing humans with an experimental vaccine to prevent the deadly Ebola virus. The NIH announced today that it is launching the safety trial on a vaccine developed by the agency's National Institute of Allergy and Infectious Diseases and GSK. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Fast Tracks Pfizer's C.diff Vaccine

August 29, 2014 2:00 pm | News | Comments

Pfizer Inc. has announced  that the FDA has granted Fast Track designation to the company’s investigational Clostridium difficile vaccine candidate (PF-06425090). Read more...                 

TOPICS:

Amgen Submits BLA for Cholesterol-Lowering Pill

August 29, 2014 2:00 pm | News | Comments

Amgen has announced the submission of a Biologics License Application (BLA) to the FDA for evolocumab seeking approval for the treatment of high cholesterol. Read more...                       

TOPICS:

Isis Initiates Phase 3 Study of FCS Drug

August 29, 2014 2:00 pm | News | Comments

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial chylomicronemia syndrome (FCS). FCS is a rare orphan disease, characterized by extremely high triglyceride levels, that affects an estimated 3,000 to 5,000 patients worldwide. Read more...

TOPICS:
Advertisement

Drug-Delivery Vehicle Could Limit Spread of HIV, AIDS

August 29, 2014 2:00 pm | News | Comments

A unique method for delivering compounds that could positively impact the global battle against HIV and AIDS may be possible, according to new research. Read more...                         

TOPICS:

Synthesis Produces New Antibiotic

August 29, 2014 2:00 pm | News | Comments

A  collaboration at Rice University has led to the total synthesis of a recently discovered natural antibiotic. The laboratory recreation of a fungus-derived antibiotic, viridicatumtoxin B, may someday help bolster the fight against bacteria that evolve resistance to treatments in hospitals and clinics around the world. Read more...

TOPICS:

Amgen's Cholesterol-Lowering Drug Meets Co-Primary Endpoints

August 29, 2014 8:30 am | News | Comments

Amgen announced that the Phase 3 YUKAWA-2 study evaluating evolocumab in combination with statin therapy in Japanese patients with high cardiovascular risk and high cholesterol met its co-primary endpoints. Read more...       

TOPICS:

An End to Drug Errors?

August 29, 2014 8:30 am | News | Comments

MIT alumni have devised the MedEye, a bedside medication-scanning system that uses computer vision to identify pills and check them against medication records, to ensure that a patient gets the right drug and dosage. Read more...       

TOPICS:

Synthetic Biologics Improves Enzyme for C.diff Prevention

August 29, 2014 8:30 am | News | Comments

Synthetic Biologics, Inc. and FUJIFILM Diosynth Biotechnologies UK Limited have announced confirmation of exceptional results from the initial phase of cGMP manufacturing of SYN-004, Synthetic Biologics' proprietary oral beta-lactamase enzyme for the prevention of Clostridium difficile (C. difficile) infections. Read more...

TOPICS:
Advertisement

Accelerate Drug Development with Optimized Content Management

August 29, 2014 8:30 am | by Steve Scribner, Principal Consultant – Life Sciences, EMC Information Intelligence Group | Articles | Comments

Getting a new drug from the laboratory to the pharmacy takes years of testing, applications and information sharing. One way to shorten the drug development life cycle is to optimize content management. Read more...          

TOPICS:

New Drug Ups OS in Stage III Colon Cancer

August 28, 2014 2:00 pm | News | Comments

A subset of patients with Stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study. Read more...                          

TOPICS:

Compound Promises Relief for Inflammatory Pain

August 28, 2014 2:00 pm | News | Comments

Researchers have discovered that a compound they developed could potentially serve as a painkiller, with particular utility for East Asians with an alcohol-metabolizing enzyme mutation. Read more...                

TOPICS:

HIV Drug Dosage May Be Ineffective for African-Americans

August 28, 2014 2:00 pm | News | Comments

Many African-Americans may not be getting effective doses of the HIV drug maraviroc, a new study suggests. The initial dosing studies, completed before the drug was licensed in 2007, included mostly European-Americans, who generally lack a protein that is key to removing maraviroc from the body. Read more...

TOPICS:

Researchers Investigating New MS Treatment

August 28, 2014 2:00 pm | News | Comments

A new treatment under investigation for multiple sclerosis (MS) is safe and tolerable in Phase 1 clinical trials, according to a new study. The Phase 1 studies were the first to test the drug candidate in humans. Read more...     

TOPICS:

High-Performance, Multi-Position Reaction Block

August 28, 2014 10:24 am | Product Releases | Comments

The DrySyn MULTI from Asynt converts any standard hotplate stirrer into a high performance reaction block accommodating 3 round-bottomed flasks or up to 12 reactions in tubes or vials.

ChIP Sequencing Kit for NGS

August 28, 2014 10:17 am | Product Releases | Comments

The ChIP sequencing assay kit from Porvair Sciences extends the benefits of their proprietary Chromatrap solid state ChIP technology to preparation of purified Chromatin for the generation of sequencing libraries.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading